StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · TXMD·Healthcare

TherapeuticsMD, Inc. Stock Analysis & AI Score

TherapeuticsMD, Inc. (TXMD) has an ST Score of 54.0 (B-), driven by its Financial Strength (A-) and held back by its Growth (C-). Analysts rate it Buy.

Market Closed
$2.13
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
54
ST Score
54.0/100B-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

TXMD
54.0out of 100
Grade B-

TherapeuticsMD, Inc. (TXMD) has an ST Score of 54.0 (B-), driven by its Financial Strength (A-) and held back by its Growth (C-). Analysts rate it Buy.

Strongest
Financial StrengthA-
Weakest
GrowthC-
All factor grades
  • Financial StrengthA-
  • MomentumB
  • ProfitabilityB-
  • ValuationC+
  • GrowthC-
  • Piotroski4/9
Score methodology
Press Releases

Contact

TXMD stock: frequently asked questions

What is TXMD's ST Score?

TherapeuticsMD, Inc. (TXMD) has an ST Score of 54.0 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is TXMD a buy, hold, or sell?

Analysts rate TXMD a Buy. Our ST Score grades it B- (54.0/100). The ST Score is a data-driven signal, not a recommendation.

What are TXMD's factor grades?

Valuation C+, Profitability B-, Financial Strength A-, Momentum B, Growth C-.

What is TXMD's valuation grade?

TherapeuticsMD, Inc. (TXMD) earns a valuation grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is TXMD's growth grade?

TherapeuticsMD, Inc. (TXMD) earns a growth grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is TXMD's profitability grade?

TherapeuticsMD, Inc. (TXMD) earns a profitability grade of B-, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is TXMD's financial strength grade?

TherapeuticsMD, Inc. (TXMD) earns a financial strength grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is TXMD's Piotroski score?

TherapeuticsMD, Inc. (TXMD) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.